The healthcare expenditure on prescribed medicines in Poland has experienced a consistent downward trend from 2013 to 2023, with expenditure decreasing from 10.29 units in 2013 to 7.64 units in 2023. The most recent two years showed year-on-year declines of -3.06% in 2022 and -3.54% in 2023, with the average variation per year (CAGR) over the last five years standing at -4%. For the forecasted period from 2024 to 2028, the CAGR is expected to be -3.25%, resulting in a projected expenditure of 6.24 units by 2028, representing an overall decline of -15.22%.
Future trends to watch for:
- The impact of demographic changes such as an aging population on healthcare demands.
- Potential changes in government policy regarding healthcare funding and pharmaceutical regulations.
- The influence of new medical technologies and corresponding shifts in treatment paradigms.
- Economic factors like inflation and budget allocations that could affect healthcare funding decisions.
Latest reports
US Erectile Dysfunction Market Report- Q1 2025
The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...
South Korea Erectile Dysfunction Market Report- Q4 2024
The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...
Spain Erectile Dysfunction Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...
